Concepedia

Marisa J.L. Aitken

MJ

Statistics

Publications

6

Citations

189

H-Index

6

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

ImmunoGen (United States)

Marisa J.L. Aitken is an author at The University of Texas MD Anderson Cancer Center specializing in tumor biology, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

2019–2022

6

Publications

6

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy

Sankaranarayan Kannan, Mary E. Irwin, Shelley M. Herbrich et al. · Antioxidants · 2022 · 53 citations · Full text

, , +18

Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas

Miguel Gallardo, Prerna Malaney, Marisa J.L. Aitken et al. · JNCI Journal of the National Cancer Institute · 2019 · 42 citations · Full text

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

Shelley M. Herbrich, Natalia Baran, Tianyu Cai et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemia

Sean M. Post, Huaxian Ma, Prerna Malaney et al. · Haematologica · 2021 · 31 citations · Full text

, , +19

Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

Sankaranarayanan Kannan, Marisa J.L. Aitken, Shelley M. Herbrich et al. · Molecular Cancer Therapeutics · 2019 · 14 citations · Full text

1–5 of 6